Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortage
Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortage Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortage